透皮电声刺激通过自主机制改善便秘症状,并通过自主机制加速慢过渡便秘患者的结肠过渡
Jingze Yang1, Jinlu Guo1, Ying Ba1
1Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Neuromodulation : journal of the International Neuromodulation Society
|December 21, 2023
概括
穿皮电刺激 (TEA) 为缓慢过渡便秘 (STC) 提供了持续的,非侵入性的治疗方法. 这种疗法通过增强结肠过渡和阴道神经活动来改善肠道运动,生活质量和心理健康.
科学领域:
- 胃肠病学 胃肠病学
- 神经学 神经学
- 综合医学是一个整体的医学.
背景情况:
- 慢过渡性便秘 (STC) 影响了近一半的患者,他们对传统治疗不满意.
- 需要有效的,非侵入性的治疗方案来管理STC.
研究的目的:
- 评估ST36针点在STC患者体皮电声刺激 (TEA) 的治疗效果.
- 调查TEA在STC治疗效果的潜在潜在机制.
主要方法:
- 一项随机对照试验涉及70名STC患者,分为TEA和假TEA组.
- 一个为期两周的治疗期,然后进行生理评估 (心电图,心力测量,结肠过境,血液检查) 和一个为期两周的洗.
- 在ST36针点施加TEA,假TEA作为对照.
主要成果:
- 盲人TEA显著增加了自发性肠道排便和降低了便秘症状得分,效应持续在洗后.
- 在STC患者中,TEA改善了生活质量和心理状态.
- 从机械上讲,TEA加速了结肠过渡,增强了阴道神经活动 (通过心率变化分析),并减少了循环中的血管活性肠.
结论:
- 非侵袭性TEA可持续缓解便秘,并改善STC患者的整体幸福感.
- TEA的治疗益处与加速结肠过境和减少由神经介导的血管活性肠道有关.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
176
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
176
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
213
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
213
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
264
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
264
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
86
This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
86
Drugs Affecting GI Tract Motility: Other Laxatives
227
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
227
Drugs for Treatment of Diarrhea-Predominant IBS
179
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
179


